Anjali Singh, Business Standard

All stories by Anjali Singh, Business Standard

'You End Up Firefighting': Finance Minister
Rediff.com1 days ago

'Uncertainty level A in the morning, uncertainty level B in the afternoon. If I answer...

'India Is A Reverse AI Trade Globally'
Rediff.com2 days ago

'The day that the market realises that they've overspent (on AI) and there's a sudden...

AI Can Make India World's Creative Capital
Rediff.com6 days ago

'Not the back office for the world's content. The leader. The standard-setter.'

Hyderabad claims its place as global MNC destination
Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs)...

Electric vehicle retail sales zoom in Jan
Rediff.com12 Feb 2026

India's electric vehicle (EV) markets expanded gains in January compared to the...

Rare-Disease, Cancer Drugs Get Cheaper
Rediff.com3 Feb 2026

For patients, the immediate impact is a reduction in the final cost of therapies that...

Bajaj Auto logs best quarterly earnings in Q3
Rediff.com31 Jan 2026

Two-wheeler (2W) major Bajaj Auto on Friday posted its highest ever quarterly revenue...

E2W companies seek PM E-Drive subsidy extension beyond March 2026
Rediff.com27 Jan 2026

India's electric two-wheeler (e2W) manufacturers have urged the government to extend...

Southern states hold the steering wheel in India's ePV transition
Rediff.com20 Jan 2026

India's electric passenger vehicle (ePV) market has expanded sharply over the past five...

Two-wheeler Industry hits speed bump over ABS mandate
Rediff.com19 Jan 2026

India's two-wheeler industry is seen growing 6-9% in 2026, though a proposed ABS...

SUVs rule resale market despite small cars getting cheaper
Rediff.com13 Jan 2026

Data from used-car platforms suggest that buyer preferences have remained broadly...

Carmakers Go Deep In Bid To Expand Beyond Metros
Rediff.com12 Jan 2026

Network scale seen as central to tapping smaller markets.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025
Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious...

Northern Borders 'Stable Yet Sensitive': Defence Ministry
Rediff.com3 Jan 2026

The deployment of the army in all sectors along the Line of Actual Control, the de...

3.84 Trillion Spent On These Weapons...
Rediff.com2 Jan 2026

The largest tranche came in July, in the wake of Operation Sindoor, with the DAC...

India's diagnostic chains are in expansion mode. Here's why
Rediff.com29 Dec 2025

India's diagnostics sector is accelerating capacity addition and geographic expansion,...

Carmakers Gear Up To Hit Refresh Button
Rediff.com27 Dec 2025

'In India's competitive automotive market, staying relevant means continuously raising...

Cancer Therapies Break New Ground
Rediff.com26 Dec 2025

'India is clearly moving toward more targeted treatment pathways in high-burden cancers.'

Emcure sets sights on pan-Indian obesity market with Poviztra
Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide...

SIM-Binding Standoff: Telcos Vs Apps
Rediff.com17 Dec 2025

App-based communication services providers and Indian telcos are at loggerheads over...